{"id":"https://openalex.org/W77353407","doi":"https://doi.org/10.1096/fasebj.24.1_supplement.571.3","title":"Inhibition of NADPH oxidase restores vasoreparative function in diabetic CD34+ cells","display_name":"Inhibition of NADPH oxidase restores vasoreparative function in diabetic CD34+ cells","publication_year":2010,"publication_date":"2010-04-01","ids":{"openalex":"https://openalex.org/W77353407","doi":"https://doi.org/10.1096/fasebj.24.1_supplement.571.3","mag":"77353407"},"language":"en","primary_location":{"id":"doi:10.1096/fasebj.24.1_supplement.571.3","doi":"https://doi.org/10.1096/fasebj.24.1_supplement.571.3","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.24.1_supplement.571.3","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037915418","display_name":"Yagna P. R. Jarajapu","orcid":"https://orcid.org/0000-0002-7186-3693","observed_orcids":["https://orcid.org/0000-0002-7186-3693"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yagna PR Jarajapu","raw_affiliation_strings":["Pharmacology &amp; Therapeutics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology &amp; Therapeutics","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111552124","display_name":"Sergio Caballero","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sergio Caballero","raw_affiliation_strings":["Pharmacology &amp; Therapeutics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology &amp; Therapeutics","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100701724","display_name":"Qiuhong Li","orcid":"https://orcid.org/0000-0003-4211-6514","observed_orcids":["https://orcid.org/0000-0003-4211-6514"]},"institutions":[{"id":"https://openalex.org/I2800717037","display_name":"University of Florida Health","ror":"https://ror.org/04tk2gy88","country_code":"US","type":"education","lineage":["https://openalex.org/I2800717037","https://openalex.org/I33213144"]},{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qiuhong Li","raw_affiliation_strings":["Ophthalmology University of Florida Gainesville FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ophthalmology University of Florida Gainesville FL","institution_ids":["https://openalex.org/I2800717037","https://openalex.org/I33213144"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083537513","display_name":"Maria B. Grant","orcid":"https://orcid.org/0000-0002-6470-0255","observed_orcids":["https://orcid.org/0000-0002-6470-0255","https://orcid.org/0000-0002-3602-8844","https://orcid.org/0000-0001-8571-4827"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Grant","raw_affiliation_strings":["Pharmacology &amp; Therapeutics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology &amp; Therapeutics","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3740,"currency":"USD","value_usd":3740},"apc_paid":null,"fwci":0.2165,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.59686439,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"24","issue":"S1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10155","display_name":"Nitric Oxide and Endothelin Effects","score":0.6104000210762024,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10155","display_name":"Nitric Oxide and Endothelin Effects","score":0.6104000210762024,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.3334999978542328,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11597","display_name":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","score":0.017400000244379044,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nadph-oxidase-inhibition","display_name":"NADPH oxidase inhibition","score":0.9810000061988831},{"id":"https://openalex.org/keywords/endothelial-progenitor-cells","display_name":"endothelial progenitor cells","score":0.8539999723434448},{"id":"https://openalex.org/keywords/cd34-cells","display_name":"CD34+ cells","score":0.9509999752044678},{"id":"https://openalex.org/keywords/type-1-diabetes","display_name":"type 1 diabetes","score":0.890999972820282},{"id":"https://openalex.org/keywords/retinal-ischemia-reperfusion-injury","display_name":"retinal ischemia-reperfusion injury","score":0.8849999904632568},{"id":"https://openalex.org/keywords/endothelial-nitric-oxide-synthase","display_name":"endothelial nitric oxide synthase","score":0.902999997138977},{"id":"https://openalex.org/keywords/nitric-oxide","display_name":"nitric oxide","score":0.8880000114440918},{"id":"https://openalex.org/keywords/cgmp","display_name":"cyclic GMP","score":0.9359999895095825},{"id":"https://openalex.org/keywords/cxcl12","display_name":"CXCL12","score":0.8569999933242798},{"id":"https://openalex.org/keywords/apocynin","display_name":"apocynin","score":0.8769999742507935},{"id":"https://openalex.org/keywords/gp91phox","display_name":"gp91phox","score":0.8679999709129333},{"id":"https://openalex.org/keywords/reactive-oxygen-species","display_name":"reactive oxygen species","score":0.9649999737739563}],"concepts":[{"id":"https://openalex.org/C2777209548","wikidata":"https://www.wikidata.org/wiki/Q414754","display_name":"Apocynin","level":4,"score":0.920333981513977},{"id":"https://openalex.org/C2779719074","wikidata":"https://www.wikidata.org/wiki/Q2038057","display_name":"NADPH oxidase","level":3,"score":0.724816083908081},{"id":"https://openalex.org/C2778326061","wikidata":"https://www.wikidata.org/wiki/Q1761022","display_name":"Enos","level":4,"score":0.5698460936546326},{"id":"https://openalex.org/C10205521","wikidata":"https://www.wikidata.org/wiki/Q4035578","display_name":"CD34","level":3,"score":0.5455659031867981},{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.5292218327522278},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5265864729881287},{"id":"https://openalex.org/C519581460","wikidata":"https://www.wikidata.org/wiki/Q207843","display_name":"Nitric oxide","level":2,"score":0.4885636270046234},{"id":"https://openalex.org/C201750760","wikidata":"https://www.wikidata.org/wiki/Q1896218","display_name":"Progenitor cell","level":3,"score":0.47353169322013855},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3866976499557495},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34708961844444275},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.34539589285850525},{"id":"https://openalex.org/C48349386","wikidata":"https://www.wikidata.org/wiki/Q424361","display_name":"Reactive oxygen species","level":2,"score":0.30276522040367126},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.29497718811035156},{"id":"https://openalex.org/C2777622882","wikidata":"https://www.wikidata.org/wiki/Q417619","display_name":"Nitric oxide synthase","level":3,"score":0.2688576281070709},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.26340487599372864},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.2605191469192505},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.23096007108688354},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1979409158229828},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.11579012870788574}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1096/fasebj.24.1_supplement.571.3","doi":"https://doi.org/10.1096/fasebj.24.1_supplement.571.3","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.24.1_supplement.571.3","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W363933927","https://openalex.org/W2002724549","https://openalex.org/W2009046724","https://openalex.org/W4403246144","https://openalex.org/W2035334171","https://openalex.org/W2133616593","https://openalex.org/W3178797404","https://openalex.org/W2113936086","https://openalex.org/W6948543156","https://openalex.org/W1977312306"],"abstract_inverted_index":{"We":[0],"have":[1],"previously":[2],"showed":[3],"that":[4,163,182],"inhibition":[5,187],"of":[6,24,42,51,86,95,100,150,193],"NADPH":[7,43,185],"oxidase":[8,44,186],"corrected":[9],"diabetic":[10,52,114,151,194],"migratory":[11],"defect":[12],"in":[13,91,102,113,138],"circulating":[14],"putative":[15],"endothelial":[16],"progenitor":[17],"cells":[18,58,88,153,166],"(CD34+)":[19],"by":[20,67,155],"decreasing":[21],"the":[22,40,47,189],"production":[23,80,137],"reactive":[25],"oxygen":[26],"species":[27],"(ROS)":[28],"thereby":[29],"increasing":[30],"intracellular":[31,76,132],"nitric":[32,71],"oxide":[33,72],"(NO).":[34],"In":[35,142],"this":[36],"study,":[37],"we":[38],"evaluated":[39,90],"effect":[41,126],"blockade":[45],"on":[46,127],"vascular":[48,148,190],"engraftment":[49,84,191],"potential":[50,85,192],"CD34+":[53,57,87,152,195],"cells.":[54,118,196],"Peripheral":[55],"blood":[56],"were":[59,81],"isolated":[60],"from":[61],"healthy":[62],"and":[63,78,135,167],"Type":[64],"1\u2010diabetic":[65],"individuals":[66],"immunomagnetic":[68],"selection.":[69],"Endothelial":[70],"synthase":[73],"(eNOS)":[74],"activity,":[75],"NO":[77,133],"cGMP":[79,136],"quantified.":[82],"Vascular":[83],"was":[89,111,158,168],"a":[92],"mouse":[93,143],"model":[94],"retinal":[96,144],"ischemia/reperfusion":[97],"injury.":[98],"Activation":[99],"eNOS":[101,128],"response":[103,139],"to":[104,116,140,162],"stromal":[105],"derived":[106],"factor\u20101":[107],"(SDF1,":[108],"100":[109],"nM)":[110],"lower":[112,160],"compared":[115,161],"non\u2010diabetic":[117,165],"Treatment":[119],"with":[120,164,175],"apocynin":[121,176],"or":[122,177],"gp91ds\u2010tat":[123],"has":[124],"no":[125],"activity":[129],"but":[130],"increased":[131,170],"levels":[134],"SDF1.":[141],"I/R":[145],"injury":[146],"model,":[147],"incorporation":[149],"followed":[154],"intravitreal":[156],"injection":[157],"significantly":[159,169],"after":[171],"ex":[172,183],"vivo":[173,184],"treatment":[174],"gp91ds\u2010tat.":[178],"These":[179],"results":[180],"suggest":[181],"increases":[188]},"counts_by_year":[{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}
